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4Foreword
The current supplementary programme of the High Flux 
Reactor (HFR), fi nanced by France, Germany and The 
Netherlands, is managed by the JRC and covers the period 
2000-2003. The HFR, located in Petten, The Netherlands, 
is one of the most powerful multi-purpose research and 
test reactors in the world and today its operation has been 
entrusted to the Nuclear Research and consultancy Group 
(NRG). Having provided irradiation and post-irradiation 
examination services for decades, its mission was extended 
in recent years to medical support both through the 
production of radioisotopes and patient treatment at the 
Boron Neutron Capture Therapy Facility (BNCT). Today, 
the HFR is the European leader in terms of radioisotope 
production volume and one of the European pioneers in 
BNCT research activities.
In 2002, further to additional indications on weld anomalies 
discovered in the summer 2001 inspection, serious concerns 
were voiced about the safety of the plant. Accordingly, 
on 8 February 2002, in agreement with NRG and the 
Dutch nuclear safety authority, the “Kernfysische Dienst” 
(KFD), the European Commission decided to temporarily 
shut down the reactor. This shut-down period was used for 
an external safety culture review performed by an expert 
group of the International Atomic Energy Agency (IAEA), 
for the defi nition  of an improvement action plan and for an 
external inspection of the welding anomaly observed during 
the 2001 inspection. 
The IAEA review concluded that the reactor was in good 
condition and made recommendations and suggestions 
for further safety improvements. As a consequence, a 
programme on safety culture improvement was set-up. In 
addition, following the  external inspection of the welding 
anomaly,  a comprehensive plan for structural assessment 
was devised. These actions allowed the reactor to start 
again on 22 March and operations have continued normally 
since then. A new in-service inspection will take place before 
the end of the summer of 2003.
The shutdown raised major concerns for the continued 
supply of medical radioisotopes. The issue was raised 
during an emergency debate in the Dutch Parliament in 
February 2002 and re-emphasized this crucial aspect of 
HFR’s role in our society. 
The experimental activities were carried out as explained in 
this annual report.
At the time of writing this foreword, I am pleased to state 
that both the IAEA action plan on safety culture improvement 
and the plan for structural assessment are progressing as 
planned thanks to the efforts devoted since the events in 
February 2002.
Marc Becquet
September 2003
5The High Flux Reactor (HFR) Petten, managed by the Institute 
for Energy 1 (IE) of the JRC of the European Commission, 
is one of the most powerful multi-purpose materials testing 
reactors in the world.
The HFR is of the tank-in-pool type, light water cooled and 
moderated and operated at 45 MW. In operation since 
1961, and following a new vessel replacement in 1984, the 
HFR has a technical life beyond the year 2015.
The reactor provides a variety of irradiation facilities and 
possibilities, [1], [2]: in the reactor core, in the refl ector 
region and in the poolside. Horizontal beam tubes are avail-
able for research with neutrons. Gamma irradiation facilities 
are also available. Excellently equipped hot cell laborato-
ries, on the Petten site, can provide virtually all envisaged 
post-irradiation examinations.
The close co-operation between JRC and NRG 2 on all 
aspects of nuclear research and technology is essential 
to maintain the key position of the HFR amongst research 
reactors world-wide [3][4][5]. This co-operation has led to 
a unique HFR structure, in which both organisations are in-
volved. JRC is the owner of the plant (in fact only for a lease 
of 99 years), the plant- and budget manager and the licence 
holder. JRC develops a platform around HFR as a tool for 
European collaborative programmes. NRG operates and 
maintains the plant, under contract, for JRC and manages, 
since the 2000/2003 programme, the commercial activities 
around the reactor.
Furthermore each organisation provides complementary 
possibilities around the reactor activities, such as the hot cell 
facilities of NRG or the experiment commissioning labora-
tory of JRC.
HFR is also in the core of the Medical Valley association. 
This association between IE, NRG, Tyco (Mallinckrodt Medi-
cal), Urenco and hospitals leads to a Centre of Excellence, 
unique in Europe.
A co-operation agreement for the use of HFR beam tubes 
was signed in 1999 between JRC, NRG and IRI Delft 3. This 
agreement allows free access of the IRI teams to the HFR 
beam tubes and allows a fruitful collaboration in the techno-
logical improvement of the HFR beam tubes.
Introduction
1  Since 1st September 2001 the name Institute for Advanced Materials 
is changed to Institute for Energy (IE)
2  Nuclear Research and consultancy Group (NRG) is a company 
(with 40 years of experience!) established in 1998 through the merger 
of the nuclear activities of ECN (The Netherlands Energy Research 
Foundation) and KEMA
3  Interfaculty Reactor Institute, Delft University of Technology, Delft, 
The Netherlands
6HFR main fi gures
In 2002, the HFR was in operation during 275 days. This 
fi gure is to be compared with an original planning of 290 
operation days before the reactor stop (see paragraph be-
low) and a planning of 270.3 operation days further to the 
stop. Nominal power has been 45 MW with a total energy 
production of approximately 12383 MWd, corresponding 
to a fuel consumption of about 15.5-kg of U-235.
The HFR budget and split of activities is shown below.
HFR budget
Dutch contribution
34.0 Mio e (52%)
Commercial and 
competitive activities 
26.1 Mio e (40%)
German contribution
3.8 Mio e (6%)
French contribution
1.2 Mio e (2%)
HFR activities
Radioisotopes production (41%)
Radioisotopes development (6%)
Fundamental research 
and training (12%)
BNCT and activation analysis (12%)
Safety improvement 
of existing reactors (12%)
Waste management (3%)
Fusion (14%)
HFR operation, management
Following allegations related to safety and safety culture 
at the High Flux Reactor (HFR), the HFR underwent an 
enforced shut down for a full cycle and two reviews were 
carried out. Positive outcomes from both reviews as well 
as support statements from the Dutch Safety Authority and 
the Environment Minister led to a restart of the HFR on 22 
March. IE has committed itself to full implementation of 
the recommendations and improvement suggestions in the 
reports. 
As part of the continuous safety plan, the HFR holds every 
three years a large-scale simulation of a nuclear accident 
to test the operation of the emergency contingency plan 
for the Petten site. In 2002, one such exercise was held 
on 22 April. Over 150 people were involved, including 
the fi re service, police, ambulance teams, special medical 
units, local hospitals, and even the army who set up and 
demonstrated a special decontamination facility. The 
exercise specifi cally aimed at testing com mu nication and 
co-ordination between the different emergency services 
on-site and the crisis management team.
Fusion
HFR contributes to the fusion technology development 
by providing experimental results utilising the HFR 
as the neutron source and the hot cell laboratory 
to perform post-irradiation testing. The main areas 
of interest are the ITER vacuum vessel, the blanket 
development, and the development of the reduced 
activation materials: chromium steel and ceramic 
composites.
Highlights
7Fission
In the frame of the Shared-Cost Action ADIMEW, a 
major campaign was successfully completed for 3-D 
mapping of residual stresses in a 51-mm thick dissimilar 
metal piping weld. The obtained results confi rm the 
feasibility of such testing based on the LCNDF. These 
results will be used by major European industrial and 
academic organisations for the calibration of advanced 
numerical techniques for the prediction of such internal 
stresses.
On 27-28 March a workshop on irradiated stress 
corrosion cracking in reactor internals was organised 
in Petten by the Ageing Materials European Strategy 
(AMES) European Network. 25 participants agreed to 
the set-up of a dedicated European network.
In co-operation with the European Nuclear Society 
and the International Atomic Energy Agency (IAEA), IE 
hosted the highly successful 3-day HTR Conference from 
22 to 24 April, which was attended by 185 participants 
from 18 countries, including China, USA, South Africa, 
Korea and the Russian Federation. 
The NET European Network on Neutron Techniques 
Standardisation was launched on 23-24 May. 26 
organisations attended the kick-off meeting. The scope 
of the network covers experimental and analytical 
studies, evolution of internal stresses and microstructure 
and defects due to welding and heat treatment.
Medical applications
The 2002 reactor stop highlighted the importance of HFR 
as a worldwide supplier of medical radioisotopes.
Treatment of the last patient in the current BNCT trial was 
fi nalised, bringing the total to 26 patients covering more 
than 100 treatment days. The outcome of the treatments 
so far has shown that there are no negative effects on 
tissues surrounding the cancer and that the expectancy 
and quality of life of the treated patients is at least as 
good as for conventional treatments.
The 10th International Congress on Neutron Capture 
Therapy (NCT) was co-organised by JRC-IE in Essen on 
8-13 September. Almost 280 participants from around 
the world agreed on placing greater emphasis on the 
clinical aspects of BNCT. Also a pre-kick-off meeting for a 
European network on NCT was held, and collaboration 
between the Petten-Essen and Boston-MIT groups for 
parallel trials was confi rmed. 
External relations
A technical co-operation agreement on safety is under 
discussion with HFR‘s two other “sister”-reactors: R2 
(Sweden) and SAFARI (South Africa).
150 visits involving a total of 955 people were 
organized at the HFR. Guided tours in the HFR, held 
during the Petten Open Day event (19 October) as well 
as the attractiveness of JRC and Commission stands, and 
the computer activities specially designed for children, 
attracted many visitors and contributed greatly to the 
huge success of the day. 
Mrs. A.-M. Jorritsma, Dutch Minister of Economic 
Affairs and Vice-Prime Minister of the Netherlands, 
visited the Institute on 8 April with representatives of 
the Dutch Directorate-General for Energy. During her 
visit the Minister discussed several energy-related topics 
with researchers from the Institute. On 11 October 
Mrs. G. Dicus, member of the US Nuclear Regulatory 
Commission (NRC), together with representatives 
from the US Embassy in Den Haag and from the US 
Delegation to the EU visited IE. In addition to discussions 
on adequate measures for the protection of public health 
and safety related to civil nuclear installations, a tour of 
a number of laboratories was organised.
8HFR operation and related services
In 2002 the regular cycle pattern consisted of a scheduled 
number of 290 operation days and two maintenance peri-
ods of 19 and 24 days. In reality the HFR was in operation 
during 275 days (Figure 1). This corresponds to an actual 
availability of 94.7 % with reference to the original sched-
uled operation plan. Nominal power has been 45 MW with 
a total energy production of approximately 12383 MWd, 
corresponding to a fuel consumption of about 15.5-kg of 
U-235.
At the beginning of the reporting period, the HFR was in op-
eration for the performance of cycle 01.12. Towards the end 
of the reporting period the reactivity measurements for the 
FLUX 2002 programme were performed. At the same time, 
the yearly HFR reactor training programme was carried out. 
Activities performed in the framework of the regular HFR op-
erators‘ training took place immediately after the scheduled 
ends of cycles 02.07, 02.08, 02.09 and 02.10.
The operating characteristics for 2002 are given in Table 1. 
HFR cycle 02.02 (originally scheduled in the operation plan) 
was cancelled due to the IAEA safety culture audit and be-
cause of subsequent additional start-up conditions outlined 
HFR:
The Reactor
OPERATING TIME SHUT-DOWN TIME
Cycle
Begin-End
HFR
Cycle
Generated 
Energy
Planned Low
Power
Nominal
Power
Other
Use
Total Planned
Unsche-
duled
Number of 
Interruptions
Stack Release
(of Ar-41)
2002 MWd hrs h.min h.min h.min h.min h.min h.min PD Scram Bq x E+11
01.01-21.01 01.12 1047.59 496 496.00 496.00   08.00 6.0
22.01-18.02 02.01 1128.85 592 01.56 599.04 601.00   71.00 6.0
19.02-18.03 02.02 592 No reactor operation performed 672.00
19.03-16.04 02.03 1123.52 592 01.42 598.53 600.35 80.00   14.25 7.0
17.04-29.04 Maintenance period 312.00
30.04-27.05 02.04 1212.31 544 06.47 643.00 649.47   22.13 6.0
28.05-24.06 02.05 1126.94 592 02.04 599.46 601.50   70.10 6.0
25.06-22.07 02.06 1133.64 592 02.08 604.06 606.14   65.41   00.05 1 6.0
23.07-12.08 Maintenance period 504.00
13.08-09.09 02.07 1126.22 592 02.02 600.28 00.28 602.58   68.57   00.05 1 6.0
10.09-07.10 02.08 1135.53 592 02.06 605.00 00.08 607.14   64.37   00.09 2 5.0
08.10-04.11 02.09 1107.37 592 01.58 589.52 05.13 597.03   75.52   00.05 1 5.0
05.11-02.12 02.10 1127.54 592 01.45 600.53 00.32 603.10   68.50 5.0
03.12-30.12 02.11 1113.93 592 02.12 590.48 31.49 624.49   47.11 2 14.0
31.12 03.01   24.00
TOTAL : 12383.44 6960 24.40 6527.50 38.10 6590.40 1482.31 686.49 2 5 72
Percentage of total time in 2002 (8760 h) : 0.28 74.52 0.43 75.24 16.92 7.84
Percentage of planned operating time (6960 h) : 0.35 93.79 0.54 94.69
PD: Power decrease
Table 1   2002 operational characteristics
9by the Dutch regulatory body as well as reactor vessel in-
service inspection. Consequently, a part of the maintenance 
activities, which were planned for March 2002, was carried 
forward to this period. A new 2002 HFR cycle programme 
was then made consequently to this period of investigation, 
measurements and maintenance. Further, the start of cycle 
02.09 was delayed by an additional inspection with respect 
to concrete ageing; this inspection was carried out by the 
Dutch regulatory body and external specialists. 
With regard to the revised annual programme where 270.3 
full power days were scheduled, the ratio of actual to sched-
uled availability rises to 100.6 %.
All details on power interruptions and power disturbance 
occurring in 2002 are provided in the fi gures above, show-
ing that 5 scrams occurred, four of which were due to human 
intervention. This value is the lowest since 1997. 
In 2002, 150 visits to the reactor, involving 955 people 
were organized. Alongside international colleagues and 
relations in the medical world, a number of people from 
the local community took advantage of the open day during 
each cycle to visit the facility.
0%
20
40
60
80
100
120
Figure 1  HFR availability
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Figure 3  HFR unscheduled shutdowns
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10
INSARR (INtegrated Safety Assessment of 
Research Reactors) mission to the HFR
At the request of the European Commission, Joint Research 
Centre, Institute for Energy, the IAEA conducted an Integrat-
ed Safety Assessment of Research Reactors (INSARR) to the 
HFR in March 2002. 
The terms of reference of the mission were defi ned in a pre-
paratory mission; they covered elements of Safety Manage-
ment and Safety Culture, Nuclear Safety, Licensing, Modifi -
cations, Quality Assurance and Emergency Planning.
A team of International Experts representing eight nationali-
ties and having a good balance of operational and regula-
tory experience conducted the review. Among the various 
members were the responsible for Safety Culture and the 
Head of the Research Reactor Safety Unit from the IAEA.
Before the mission started, it was well-known that authorities, 
mass media and specialized publications in The Netherlands 
would pay substantial attention to several issues related to 
the safety of the HFR at Petten,given that:
• defi ciencies were presumed in the Safety Culture,
• a welding joint in the reactor vessel was defect, and
• violations of safety precautions were alleged.
The mass media informed the IAEA of the above negative 
comments but also emphasised more positive aspects such 
as the HFR contribution in the fi eld of  radiopharmacy and in 
the treatment of brain tumours using BNCT.
IE/JRC, the HFR licence holder, in agreement with the Dutch 
Safety Authorities (KFD) decided as a precautionary meas-
ure, to shut down temporarily the HFR during a period that 
would include the week of the INSARR mission. Measures 
were taken to minimize the disruption of supply of medical 
radioisotopes and of treatment of cancer, whilst carrying out 
the measurements and improvements agreed upon with the 
Dutch safety authorities. Further, this shut-down would facili-
tate the participation of the operating group from NRG in 
the INSARR mission. The restart of the reactor was linked to 
the results of the INSARR mission, the results of the reassess-
ment of the weld defect and the decision of the competent 
authorities. The purpose of the re-assessment was to check 
whether the defect had grown or changed in any way.
Objectives of the mission
• To perform an assessment of the safety management and 
safety culture, to establish to what extent the safety issues 
receive their due attention from all the organizations in-
volved in the operation of the HFR.
• To verify that activities important to safety are managed, 
performed and evaluated in accordance with a suitable 
programme, safety policies and procedures to secure 
a safe operation of the reactor under all operational 
situations.
• The bases of the review are the IAEA standards and good 
international practices according to the agreed terms of 
reference. The purpose of the review was the identifi cation 
of safety issues and the provision of associated recommen-
dations or suggestions.
Safety and
Quality Management
11
Review of safety management and 
safety culture
The review was based on the major components of a safety 
management system as defi ned in the IAEA INSAG-13 
report:
“The safety management system comprises those arrange-
ments made by the organization for the management of 
safety in order to promote a strong safety culture and 
achieve good safety performance”. The major components 
of this system are illustrated in the fi gure below. 
General fi ndings
The organizations under review already possess features 
that would be helpful in any future effort to develop a good 
safety culture. Some of these features are listed below:
• Nuclear safety is recognized as important to the 
organizations.
• Technical competence is strong, providing the organi-
zations with the capability to manage complex issues.
• People are dedicated and hardworking.
• Safety culture is recognized as fundamental to good 
safety performance. 
• Many employees within the organizations are 
motivated to work safely and care for the safety of 
others who work with them. 
During the review process there was excellent cooperation 
by people from all levels of the organizations. People were 
willing to provide all information requested and were open 
in their responses to questions. This suggests that the work-
force is confi dent in its approach to issues and has a mature 
understanding of the aims of the review.
The recommendations and suggestions resulting from the 
INSARR mission formed the basis of a strategic improvement 
plan, prepared by JRC in close cooperation with NRG.
To guarantee a sustained improvement of the Safety Culture 
at the HFR, this plan  was rolled out in a global list and 
elaborated into detailed sub-actions. The progress of the im-
plementation is regularly assessed and the implementation 
will be completed by the end of 2003.
Statement of safety policy (including
standards, resources and targets)
Management structures, 
responsibilities and accountabilities
Planning (inclusing risk assessment)
Control of safety related activities
Ensuring competence
Communication and team support
Supervision
Questioning attitude
Rigorous and prudent approach
Communication
Measuring performance
Audit and review
Corrective actions and improvements
Definition of safety
requirements and
organisation
Planning, control
and support
Implementation
Audit, review and
feedback
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Survey on “your perception of HFR safety”
Self-assessment plays an important role in monitoring and 
enhancing the safety culture. As a preparatory step towards 
the HFR self-assessment, a dedicated Safety Culture Work-
ing Group issued a questionnaire which was sent to 139 
employees of JRC, NRG and KFD, who are directly involved 
with HFR activities. The questionnaire was meant to sample 
a fi rst base line of views and perceptions about safety in the 
HFR. Of the 139 questionnaires, 88% were returned by the 
four target groups:
• NRG-HFR, i.e. NRG employees working in the HFR
• NRG-other, i.e. other NRG 
employees with regular working contacts with the HFR
• JRC, i.e. JRC employees both 
directly involved in the HFR and with regular contacts
• KFD, i.e. all KFD staff.
The questionnaire consisted of 10 questions and the op-
portunity to provide suggestions concerning HFR safety. The 
results provided a general picture showing that the safety 
level of HFR was perceived to be high. Employees indicated 
that they knew to whom to go to with safety problems and 
that they did not feel obstructed to raise attention to safety 
issues. The overriding priority which safety should have in all 
activities is fully endorsed. Employees felt that they person-
ally carried responsibility for safety and had the adequate 
knowledge to do so.
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How do you rate the safety level 
of the HFR?
Do you consider your working environ-
ment ‘safe’ for yourself and for others?
Do you feel inhibited from raising any
safety-related problems?
Is safety a key component and clear
priority in your daily work?
Do you also feel responsible for the
safety level of the HFR?
Do you believe you have enough 
competence and training with respect
to safety?
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Front end 
In 1999, the decision was taken to convert the HFR to low 
enriched uranium (LEU) fuel. An exchange of diplomatic 
notes in January 2000 between the European Commis-
sion and the United States authorities ensued concerning 
the conversion to LEU and interim supply of high enriched 
uranium (HEU) from the US. As a result, an export licence 
was obtained from the US Nuclear Regulatory Commission 
allowing HEU supply from the US to fuel the HFR for a period 
of four years. Quantities authorised for the fi rst two years 
have been delivered. Arrangements for the remaining supply 
were prepared.
During the year 2002 new fuel elements and new control 
rods were inspected at the manufacturer’s site and delivered 
on schedule. A new order for manufacture and delivery of 
fuel elements and control rods was placed.
Further, a prototype LEU fuel element ordered in 2001, was 
manufactured, inspected and delivered successfully. Testing 
of this prototype element has meanwhile started.
Back end
Following successful shipments of HFR spent fuel in 2000 
(COVRA, central organisation for radioactive waste in the 
Netherlands) and 2001 (US Department of Energy Savan-
nah River site), further removal of spent fuel is under prepara-
tion to ensure continuation of HFR operation. Two shipments 
to COVRA are scheduled for 2003. A transport licence ap-
plication has been made. The shipments will be performed 
with new MTR-2 containers, which were delivered in 2002. 
After shipment, the spent fuel containers will be temporarily 
stored at the COVRA site to await unloading and transfer of 
the spent fuel to the HABOG facility for long-term storage. 
The HABOG facility (Figure 4), presently under construction 
at the COVRA site, is scheduled to become available for stor-
age of spent fuel and highly radioactive waste in the second 
half of the year 2003.
Fuel Cycle
Figure 4   HABOG facility under construction
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AMES
Executive summary & main results and achievements
The Institutional Project AMES (Ageing Materials Euro-
pean Strategies) is the framework for activities aimed to 
understand, monitor, predict and mitigate the degradation 
of critical materials for plant life management of primary 
components in nuclear reactors. Western and eastern types 
of steels are involved in the various activities. The various ac-
tivities are undertaken as international co-operation projects 
with key players in Western Europe, Accession Countries 
and NIS countries.
The main achievements are summarised in the following:
• Understanding the mechanism of irradiation 
embrittlement:
– set-up of a mechanism framework 
– synergism of Cu, P, Ni, Mn on radiation stability by 
model alloys results analysis
– role of Mn and Ni on embrittlement of high Ni steels 
by VVER-1000 surveillance data analysis (RRC-KI co-
operation)
– study of the effect of the dose rate and stress (co-opera-
tion UNRI Ukraine)
– feasibility of micro-structural analysis in  materials dam-
age evaluation
• Development of HFR irradiation rigs and irradiation cam-
paigns: irradiations for FRAME and PISA projects
• Development of non-destructive methods to monitor age-
ing (based on electric, thermo-electric, magnetic)
• Creation of a new activity /network/sector on reactor 
internals (AMALIA)
• Impact testing capabilities development
– preliminary fracture toughness testing by dynamic im-
pact using pre-cracked CVN specimens 
– validation of test practice of miniaturised (KLST) speci-
mens
HFR: The Programmes
HFR as a Tool for European Programmes
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European network management & support 
to European network strategy
The JRC has continued to support the European Network 
(E.N.) AMES (Ageing Materials European Strategy) in 
2002. AMES E.N. started its activity in 1993 with the aim 
of studying ageing mechanisms and remedial procedures for 
structural materials used for nuclear reactor components. 
Operated by JRC-IE, AMES E.N. tackles plant life manage-
ment issues by supporting the development of partnership 
projects and carrying out research projects. Examples of 
issues tackled (with relevant projects undertaken) are: 
• development of non-destructive techniques applied to 
thermal ageing and neutron embrittlement monitoring 
(GRETE, following AMES-NDT)
• improved surveillance for VVER 440 reactors (COBRA)
• dosimetry (REDOS following AMES-DOSIMETRY & 
MADAM)
• chemical composition effects on neutron embrittlement 
(PISA) and 
• advanced fracture mechanics for integrity assessment 
(FRAME)
• consolidation of the understanding of PLIM issues and 
of radiation embrittlement in particular (ATHENA)
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HTR-TN (High Temperature Reactor 
Technology Network)
Objectives
In response to growing interest in HTRs world-wide and on 
the initiative of JRC, HTR-TN was established in April 2000 
to recover, maintain and develop HTR technology from Eu-
rope and elsewhere. The ultimate goal is the development of 
advanced HTR technologies thus supporting industry in the 
design of power plants, which comply with stringent require-
ments in terms of sustainability, economic competitiveness, 
safety, waste and social acceptability. Since its creation, 
HTR-TN performed very successfully and contributed to an 
effi cient EU-wide exchange including the organization of 
specialist meetings, seminars and conferences. It co-ordinat-
ed HTR related R&D projects within the EU’s 5th Framework 
Programme and is preparing a new, consistent Integrated 
Project for the 6th Framework Programme starting in 2003. 
Further information can be found at www.jrc.nl/htr-tn. 
Achievements in 2002
JRC-IE continued operating this network, which is currently 
driven by 21 partners and observers from research and 
industry and is still growing with new partners from can-
didate countries. JRC also co-chairs all HTR-TN task groups 
(see organization chart below) dealing with the detailed 
technical achievements and with the co-ordination of R&D 
work among the partners. JRC-IE has further taken several 
initiatives to trigger closer co-operation with organizations 
in non-European countries. A particular highlight was the 
organization of HTR 2002 in Petten, a conference that at-
tracted almost 200 international specialists from all technical 
areas. The proceedings are available at www.jrc.nl/htr-tn  
(Events). A follow-up meeting is foreseen in Petten in April 
2004 and is expected to become a regular event.
Task Group 1
Strategy and Identification of further R&D actions
Chairman: D. Hittner
Co-Chairman: M. Fütterer
Strategic Task Groups Technical Task Groups
Task Group 2
Communication and Database Infrastructure
Chairman: F. Schmidt
Co-Chairman: H.H. Over
Task Group 3 (eliminated)
Information and International Relations
merged with Task Group 1
Task Group 4
Components Technology
Chairman: E. Breuil
Co-Chairman: M. Fütterer
Steering Committee
Chairman: D. Hittner
Vice-Chairman: W. von Lensa
Network Manager: M. Fütterer
Task Group 5
System and Economy Studies, Non-Electric Applications
Chairman: V. Wichers
Co-Chairman: M. Fütterer
Task Group 6
Materials Performance Evaluation
Chairman: A. Chevalier
Co-Chairman: J.H. Rantala
Task Group 7
Safety and Licensing
Chairman: J. Pirson
Co-Chairman: H. Wider
Task Group 8
High Performance Fuel
Chairman: M. Phélip
Co-Chairman: D. Haas
Task Group 9
Physics and Fuel Cycle including Waste
Chairman: W. von Lensa
Co-Chairman: D. Haas / P. Rullhusen
Figure 5   HTR-TN organization chart
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The NET European Network on Neutron Tech-
n iques Standardization for Structural Integrity 
Objectives
The aim of NET is to support progress towards improved 
performance and safety of European energy production 
systems. 
The state of the art in assessing internal stresses, micro-struc-
ture and defects in welded nuclear components - as well 
as their evolution due to operational loads and irradiation 
exposure - needs to be improved before relevant structural 
integrity assessment code requirements can safely become 
less conservative. This is valid for both experimental charac-
terisation techniques and predictive numerical algorithms. 
To address this need, 35 major industrial and research/
academic organisations have joined forces, under JRC co-
ordination, to launch NET in May 2002, representing major 
nuclear industries and most European neutron facilities from 
7 EU states and 5 Candidate Countries. During 2002 the 
NET consortium has developed three initial Technical Task 
Groups (TG). 
TG1
Basic research pilot study on residual stress analysis 
of a single bead weld on a steel plate (to be con-
ducted with more than 15 partners). 
TG2
Parametric study aiming at the valuation of stress 
relief heat treatment in welded Cr-Mo-V steel plates 
(to be conducted with more than 10 partners). This 
study is viewed as a starting activity toward the de-
velopment of novel heat treatment methods relevant 
to repair welding.
TG3
Investigation of thermal ageing effects (micro-structure 
and defects analyses) on cast duplex stainless steels 
based on small angle neutron scattering (SANS). 
Figure 6   NET kick-off meeting
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NET related HFR facilities
The HFR neutron beam facilities have enabled JRC to play 
a leading role in the development and standardisation of 
neutron methods at European and International level. Two 
neutron diffractometers - HB4 and HB5 – have been used for 
microstructure, texture and stress investigations in structural 
components. HB3b and HB8 are used for defect analyses 
based on small angle neutron scattering and radiography 
respectively. In the course of 2002 progress has been made 
toward enhancing the performance of HB4 and HB5 and 
re-commissioning of HB3b and HB8. Based on these facili-
ties a large number of experimental campaigns have been 
successfully completed primarily for residual stress mapping 
in steel alloy welds in support of institutional (NET) and com-
petitive (ADIMEW, ENPOWER, HITHEX and INTERWELD) 
nuclear safety related activities. (See below). 
HB4 
• Call for tender launched for the development of 
specimen handling container (small hot cell) with 
dedicated specimen positioning table for diffraction 
testing of irradiated weld specimens;
• Call for tender launched for the development of 
specimen furnace and auxiliary equipment for 
neutron diffraction testing at high temperatures; 
Target date for testing of furnace: June 2003
• Hot Cell (incl. aux. equip.) operational 
(Target date: End 2003)
HB5  
• Successful testing of performance of 
position sensitive detector
• Expected degree of performance 
enhancement: one order of magnitude
• Adjustment of detector settings completed, 
neutron optics alignment started
• Start of fi rst stress measurements 
(Target date: early 2003) 
HB8 
• Partially dismantled for servicing and 
repair of aged parts
• Servicing of helium coolers (fi lter units)
• Leaks detected during performance testing 
in the helium system. 
• Facility operational (Target date: Mid 2003)
HB3b 
• Preliminary study on facility’s electronics 
and software upgrade completed 
• Necessary soft- and hardware upgrading was 
initiated (late 2002 – Target date: end 2003) 
• Defect detected in cooling system of fi lter unit 
(Repair target date: mid 2003)
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NET related standardisation activities
An international standard for “residual stress determination 
based on neutron diffraction” is currently being drafted by 
an international group of experts, appointed by CEN & ISO 
and convened by the NET Manager. This group of experts 
started its work in 2001 and the fi nal draft Standard will be 
submitted for adoption in late 2003.
NET related shared cost activities
During 2002 the IE-NET team has been engaged in four 
ongoing SCAs (See below) 
In addition, a new activity fully funded by DG RTD, i.e., 
SIANC: Marie-Curie Fellowship Project on “Structural Integ-
rity Assessment of Nuclear Components based on Neutron 
Techniques” has just been started. Finally, the RESTAND 
project, co-ordinated by the NET Manager, was successfully 
completed. The main deliverable of this project provided the 
basis for the current CEN & ISO standardisation activity. 
ADIMEW 
• 3-D mapping of residual stresses in 
51-mm-thick piping dissimilar metal 
weld based on neutron diffraction
• Experimental campaign successfully completed 
• Interpretation of the results underway
• Data to be used for calibration of predictive 
FEA based numerical models.
ENPOWER  
• Assessment of novel methods for weld repair
• Residual stress analysis based on neutron 
diffraction 
• Calibration of predictive numerical models 
based on reliable test data
HITHEX 
• Development of advanced CMCs for ultra-high 
temperature heat exchangers
• Residual stress investigations in 
C/C-SiC tubular specimens
• Testing at room and high temperatures
INTERWELD 
• Investigation of stress corrosion cracking in 
RPV welded internals
• Measurement of residual stress evolution 
due to neutron irradiation
MANAGEMENT 
• Structural Analysis of the HFR Vessel based on 
Finite Element Modelling
• Preliminary Residual Stress Finite Element 
Predictions of HFR Vessel Weld 22
• Global Stress Determination based on Surface 
Strains Relief Monitoring during Panel Removal 
from Vessel A West Wall
• Re-Analysis of Pressure Loads using an Updated 
Finite Element Model
• Elasto-Plastic Analysis of the HFR Vessel under 
the Design Pressure
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Boron Neutron Capture Therapy – BNCT 
Introduction
BNCT is a tumour-targeting form of radiotherapy under de-
velopment, which currently can only be performed at nuclear 
research reactors, such as the HFR. BNCT is based on the 
ability of the isotope 10B to capture thermal neutrons to pro-
duce two highly energetic particles, i.e. a helium (α particle) 
and lithium ion, which when produced selectively in tumour 
cells, can in principle destroy cancer cells, whilst sparing the 
surrounding healthy tissue, thus opening an effective new 
modality for cancer treatment. The fi rst clinical trial on BNCT 
in Europe was started at the HFR in October 1997. Since 
then, other reactor centres in Europe are also performing 
BNCT, namely: VTT (Finland), Studsvik (Sweden) and Rez 
(Czech Republic), whilst programmes elsewhere continue in 
USA and Japan. More signifi cantly, a novel application of 
BNCT was performed in 2001 in Italy (Pavia) on an extra-
corporal treatment of liver cancer. 
The Institutional Programme on BNCT moved forward with 
some signifi cant advances in treatment planning, dosimetry 
and applications to other types of tumours.
The highlight of the year was the Tenth International Con-
gress on NCT, held in Essen Germany, which was co-organ-
ised by the IE/JRC, who had the role of Secretary-General 
(R.Moss).
Competitive activities
Clinical trial of BNCT for glioblastoma 
(EORTC 11961)
The clinical trial of BNCT for glioblastoma, progressed in 
2002 with the completion of the fourth cohort of 6 patients 
(in total since 1997: 26 patients treated in 4 cohorts). At 
present, no dose limiting effects have been observed and 
life expectancy is no worse than alternative treatment. A 
decision will be taken in 2003, as to whether to start a 5th 
cohort or not. 
New clinical trials
Under the Fifth Framework Programme, three new clinical 
trials received approval and funding in “Quality of Life and 
Management of Living Resources”, contract no. QLK3-CT-
1999-01067. The fi rst trial is an uptake study, which looks 
into the possible uptake of boron into different tumours, 
including thyroid cancer, head and neck cancer and liver 
metastases. The latter, if successful in terms of signifi cant 
uptake of boron in the cancerous cells, would be the fi rst 
step towards performing extra-corporal liver treatment (á la 
Pavia 1) by BNCT at the HFR. The second trial has the objec-
tive to study the optimisation of the delivery of the boronated 
drug (BSH) in brain tumours. The purpose is to increase (dou-
ble) the boron concentration in blood, thereby doubling the 
boron dose in the tumour, which would require only half the 
irradiation time to achieve similar doses to those applied in 
the current trial whilst only giving half the irradiation dose to 
the healthy tissue. The third trial will treat brain metastases of 
malignant melanoma using the boron compound, BPA. This 
last trial will be prepared in common with the EORTC BNCT 
Group, the EORTC Melanoma Co-operative Group and the 
Harvard/MIT BNCT group in the USA. The Principal Clini-
cal Investigator is Prof.dr.med. Wolfgang Sauerwein of the 
University of Essen. Participating hospitals and institutes are: 
Universities of Münster, Reims, Essen, VU Amsterdam, Nice, 
Graz and München, and NRG. All three protocols are still 
under evaluation, but with the aim to start all 3 in 2003.
1  T. Pinelli, A. Zonta, S. Altieri, S. Barni, A. Braghieri, P. Pedroni, 
P. Bruschi, P. Chiari, C. Ferrari, F. Fossati, R. Nano, S. Ngnitejeu Tata, 
U. Prati, G. Ricevuti, L. Roveda, C. Zonta,   “TAOrMINA: From the 
fi rst idea to the application to the human liver”, in: Research and 
Development Neutron Capture Therapy, W. Sauerwein, R. Moss, 
A. Wittig, (Eds.),  Bologna, Monduzzi Editore, 
ISBN 88-323-2909-3, 2002
HFR: The Programmes
HFR as a Tool for Medical Applications
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Other competitive (shared cost) actions 
“A Code of Practice for Dosimetry for BNCT in Europe” 
The involvement of JRC in this SCA includes dosimetry 
measurements, MCNP calculations and writing one of the 
Chapters in the fi nal Code of Practice. The fi rst two were 
completed at the beginning of the year, whilst the Chapter 
(on Quality Control) has recently been completed. This re-
quired the approval of many of the participants as well as 
approval from the Medical Physicists involved in the action. 
The project is co-ordinated by NRG Petten.
“Enabling Best Practice on Oncology: BEPRO” 
(contract no. IST-2000-25252) 
JRC Petten’s role in this Shared Cost Action is part of the 
medical evaluation phase, where patient data and images 
are transferred using custom built software packages, allow-
ing access to patient data between hospitals involved in the 
clinical trials at Petten. The facility allows the clinicians to 
review different treatment plans simultaneously on the com-
puter screen (see fi gure left), allowing immediate judgements 
to be made as to whether a new plan is required to be made 
or whether one can be chosen as the preferred plan. The 
project is now in the implementation phase and was suc-
cessfully used on 3 patients treated in this year’s phase of 
the trial. The project is co-ordinated by the University Joseph 
Fourier Grenoble. 
JRC institutional programme on BNCT
The research and development activities of BNCT at Petten 
are supported in the JRC’s Institutional Research programme. 
The four-year programme has 4 prime objectives:
• Development and maintenance of existing facility
• Support to present trials and new trials
• Treatment planning activities
• Research activities, including: neutron beam improvement 
and design; application to different types of tumours; 
application to non-cancerous diseases; development of 
patient positioning devices; improvement of dosimetry; 
investigation of boron detection techniques; and develop-
ment of microdosimetry
Continued improvements to the overall features of the facil-
ity, as well as the annual maintenance of some of the critical 
components in the liquid argon system were performed. A 
new PC was purchased to install the treatment planning 
code, NCTPlan, which is an American written code, used by 
the Harvard Medical School/MIT BNCT Group. This code 
will be used as part of the third clinical trial (see earlier) 
to start in 2003, which will be performed in parallel to the 
EORTC (Petten) trial. 
Example of (part of) two treatment plans, 
displayed using the BePrO software
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Under dosimetry development, quite a number of measure-
ments were performed using the water phantom. Various 
parameters studies were completed, which could be com-
pared to calculations as part of an action to validate the 
new NCTPlan code. Measurements were also performed 
using new dosimetry techniques based on superheated drop 
detectors 2, developed at Yale University (USA). 
More calculations were performed to look at treating 
melanoma metastases in the brain, which would require a 
homogeneous dose distribution throughout the whole brain, 
and also on liver extra-corporal treatment, as carried out in 
2001 in Pavia. In this respect, initial discussions were held 
with the University Hospital in Essen to implement such a 
treatment between Essen and Petten. The decision whether to 
proceed or not is dependent on the uptake study, mentioned 
above, on boron uptake in liver.
Tenth International Congress on Neutron Capture 
Therapy, Essen
With the University of Essen, JRC Petten was co-organiser 
of the Tenth International Congress on Neutron Capture 
Therapy, which took place between September 8 and 13 
in Essen. The congress, which is held every 2 years, was 
a great success and attracted almost 300 participants from 
all around the world. There was a much greater emphasis 
placed on the clinical aspects of BNCT, as it is now being 
performed in 5 places in Europe, i.e. three more places 
than at the time of the last international Congress two years 
ago (Osaka, October 2000). Proceedings 3 were produced 
before the Congress and were distributed at the meeting. 
The JRC Petten BNCT group presented or co-authored eleven 
papers at the congress.
3  “Research and Development in Neutron Capture Therapy”, Proceedings 
of the Tenth International Congress on Neutron Capture Therapy, 
editors: W.Sauerwein, R.Moss, A.Wittig, Bologna, Monduzzi Editore 
ISBN 88-323-2909-3, 2002
2  F. d’Errico, V.Giusti, E.Nava, M.Reginatto, G.Curzio and J.Capala, “Fast 
Neutron Spectrometry of BNCT Beams”, in: Research and Development 
Neutron Capture Therapy, W. Sauerwein, R. Moss, A. Wittig, (Eds.), 
Bologna, Monduzzi Editore, ISBN 88-323-2909-3, 2002
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Medical radioisotope production
  
Most people are not aware of the important role of nuclear 
medicine in modern healthcare: medical isotopes can save 
lives when used for early diagnosis and therapeutic treat-
ment of diseases and are indispensable for pain relief. 
One aspect of crucial importance is the regular availabil-
ity of radioactive isotopes for medical applications. Under 
the guidance of the Association of Imaging Producers and 
Equipment Suppliers (AIPES) the fi ve main medical produc-
ing European Research Reactors (see below) have therefore 
co-ordinated their reactor operation schedules. This allowed 
the medical supply chain not to be too disrupted as SCK/
CEN’s BR-2 reactor in Mol brought forward and extended a 
planned operating cycle to fi ll the gap left by the unsched-
uled HFR shutdown. 
For the HFR, the year 2002 saw a considerable increase in 
the number of irradiations and in the production of radioac-
tive isotopes for medical and industrial purposes. Despite the 
cancellation of one operating cycle in February, the irradia-
tion quantities in terms of produced activity increased signifi -
cantly and the total number of individual irradiations rose 
by 40%. This signifi cant increase in irradiations was due to 
rising demand for key isotopes, especially the short half-life 
isotopes that are essential for diagnostic and therapeutic ap-
plications in nuclear medicine and radiotherapy. 
The HFR share in the world production of the main reac-
tor-produced radioactive isotopes such as molybdenum-99, 
iodine-131, strontium-89 and iridium-192 range between 
30 and 60%. 
HFR production (% of total country needs)
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Over the years the HFR has also proven to be a reliable part-
ner for medical research and development with the regular 
supply of lutetium-177, holmium-166 and yttrium-90. These 
radioactive isotopes are destined for research institutes and 
hospitals where they are used to label monoclonal antibod-
ies, peptides and other small molecules. These combinations 
of radioactive isotope and targeting moiety emit radiation 
that destroys diseased tissue, while collateral damage to 
healthy tissue is limited. 
Research on therapeutic applications has intensifi ed in 
recent years and many clinical trials are underway. With 
the partnership of NRG, the HFR has demonstrated that lute-
tium-177 of appropriate quality can be supplied to medical 
researchers on a regular basis. 
The production of iodine-125 ‘seeds’ – small sealed sources 
for the treatment of prostate cancer – strongly increased in 
2002. Suffi cient quantities to allow the treatment of more 
than 5,000 patients were produced. The advantage for 
patients of this seed implantation therapy is that potentially 
debilitating local surgery can be avoided. 
The production of radioactive isotopes is carried out accord-
ing to HFR’s high standards for safety and protection of the 
environment. Also an effective treatment of the (medical) 
waste and safe storage is arranged in contracts with the 
Dutch Central Organisation for Nuclear Waste (COVRA). 
This ensures that the back-end of this production process is 
secure and well managed. In an additional activity (carried 
out by NRG), the components of thousands of technetium 
generators are cleaned at NRG and prepared for re-use in 
hospitals all over the world. 
In 2003, a continued increase in the range and volume of 
isotopes production is expected. Further, HFR’s privileged 
partner, NRG, is carrying out an increasing number of re-
search projects with a range of different partners.
EMIR
Nuclear medicine and radiotherapy make a vital contribution 
to the diagnosis and treatment of major disease. This role is 
likely to expand with new developments including availabil-
ity of new medical isotopes. Building on HFR’s position in 
the medical radioisotope production fi eld, EMIR (European 
Network for Medical radioIsotopes and Beam Research) 
was initiated in 2001 by the JRC-IE to identify and solve 
diffi culties that constrain nuclear medicine and radiotherapy 
development in Europe and facilitate closer interdisciplinary 
collaboration. Participating organisations include the main 
European associations of medical radiation specialists, radio-
pharmaceutical radioisotope producers, nuclear research 
reactor institutions, research organisations and the JRC. 
The steering committee established task groups focusing on 
eight key areas for development. Liaison with non-European 
organisations will be encouraged. In 2002, the EMIR project 
continued to increase the number of partners in the network, 
e.g. the Rez Institute from the Czech Republic. 
Due to the departure of the Project Leader in early 2002, the 
project could only function on a low level. Nevertheless, it 
was possible to proceed on two of the many actions within 
the EMIR Network. In the task group “Radioisotope Avail-
ability”, it was agreed (overwhelmingly) that a Survey on 
Radioisotopes was needed to complement existing surveys 
on available facilities, PET and an ESTRO survey on certain 
radioisotopes. The present survey should concentrate on iso-
topes for therapy, research, availability capacity and iden-
tify areas in Europe where shortages occur. Furthermore, 
JRC agreed under the auspices of EMIR to co-organise the 
Fifth International Conference on Isotopes to be held in Brus-
sels in 2005. At the Fourth International Conference, held 
in South Africa in March, Philippe Jehenson from the EMIR 
Group presented a paper, entitled “A European Network for 
Nuclear Medicine and Radiotherapy: EMIR”. 
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HFR: The Programmes
HFR as a Tool for Fission Reactor Technology
Currently operating Light Water Reactors (LWR) and Gas 
Cooled Reactors (GCR) were designed decades ago and 
were limited in temperature and performance due to the 
restricted availability of qualifi ed materials and the choice 
of coolants. Besides many undisputed advantages, they 
also have several drawbacks such as: large unit size, high 
investment costs, long write-off times, relative complex-
ity, limited effi ciency etc. High Temperature Reactors as 
near-term (2010) options feature numerous advantages as 
replacements of third-generation LWRs or GCRs and as new 
installations. Several HTR evolutions have been evaluated in 
the international Generation IV initiative. Feasibility studies 
for several advanced conceptual designs are conducted in 
a number of research institutes and universities worldwide 
to optimize aspects such as safety performance, sustainable 
use of fuel, minimization of waste, or economy. In Europe, 
signifi cant efforts are dedicated to the recovery of the knowl-
edge on the once fully mastered fuel fabrication and on the 
qualifi cation of materials. 
Euratom is interested in participating in and supports Gen-
eration IV and can provide signifi cant input from past HTR 
experience and for emerging projects on gas-cooled reac-
tors. The JRC-IE contribution is integrated in projects provid-
ing technical contributions in the fi elds of fuel and material 
irradiations, out-of-pile testing and data management. The 
strong on-site synergies between NRG and JRC installations 
are used and the long-term expertise in advanced materials 
development and irradiation testing in the HFR is maintained 
and constantly improved.
HTR fuel irradiations
Objectives
The irradiation of LEU fuel types in the HFR is under prepara-
tion to study in particular its resistance to radioactive fi ssion 
product release with increasing burn-up. Pre- and post-ir-
radiation examinations will be conducted to test the safety 
relevant quality and temperature limits of the irradiated fuel. 
The results of these experiments are expected to provide ori-
entations for further improvement of fuel technology. More 
specifi cally, the irradiation projects are:
• Irradiation of pebble type fuel produced by NUKEM, Ger-
many and INET, China, codename HFR-EU1 with on-line 
fi ssion gas release monitoring.
• Irradiation of pebble type fuel produced by NUKEM, 
Germany to high burn-up, codename HFR-EU1bis with 
simplifi ed fi ssion gas monitoring.
• Irradiation of compact type fuel produced by General 
Atomics, USA, codename HFR-EU2 with on-line fi ssion gas 
release monitoring.
Achievements in 2002
For all three irradiation tests, detailed design studies 
were performed including drawings and instrumentation. 
Neutronic and thermal analyses were subcontracted. The 
irradiation HFR-EU1bis was set-up additionally to catch up 
with the delay of the two other irradiation tests by providing 
irradiated fuel spheres for safety-relevant thermal ramp tests 
at JRC-ITU. For HFR-EU2, JRC-IE successfully managed to use 
pre-irradiated fuel compacts with confi rmed excellent fi ssion 
product retention properties (delivered by General Atomics). 
For all irradiation tests, fabrication and subcontracting was 
launched. The gas circuits with fi ssion gas analysis systems 
were designed and assembly has started.
In the future, further irradiation tests of advanced MOX, plu-
tonium or thorium fuel as well as specifi c fuel for the incinera-
tion of nuclear waste in HTRs may be envisaged.
HTR fuel irradiation rig and telated auxiliary equipment in the HFR
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HTR: structural materials irradiation and 
out-of pile tests
Objectives
These tests aim at investigating the in-pile and out-of-pile 
properties of high-temperature materials to be used within 
an HTR core, e.g. as pressure vessel material and for control 
rods. Specimens of candidate materials will be irradiated at 
temperatures typical for their envisaged use in an HTR. Post-
irradiation testing will focus on determining the mechanical 
properties. The materials to be tested include metallic super-
alloys or ceramic and fi bre composite materials. The expo-
sure in particular of the metals for longer periods to high 
temperatures and different helium chemistries may carburize 
or decarburize them, thus altering their mechanical proper-
ties; this alteration has to be quantifi ed.
Achievements in 2002
Signifi cant out-of-pile material testing activities were pre-
pared for the conventional part of an HTR power plant, in 
particular for high temperature helium turbines and helium-
helium heat exchangers. The required installations were 
designed, modifi ed and tested.
For the future, irradiations of improved graphite and refl ec-
tor materials as well as alternative matrix materials and 
neutron poisons may be envisaged.
Development of an HTR fuel database
Objectives
Numerous irradiation tests of earlier HTR fuel types were 
already conducted some 30 years ago in the HFR and 
elsewhere. In this context, a database application (Fuel-DB) 
for experimental results was developed in order to recover, 
maintain and utilize a maximum of HTR fuel related informa-
tion. The success of the Fuel-DB activity is obviously depend-
ent upon the quality of the data input. Whilst the immediate 
objective is to recover a maximum of data from archived 
documents, the primary aim is to ensure that in the future, 
experimental data is stored at the source, i.e. piped directly 
from the test facility to the database.
Achievements in 2002
In co-operation with the HTR-F project, the structure, i.e. the 
type and degree of detail to be listed, of the fuel database 
was defi ned. The database is operational and ready to be 
fi lled with data by the project partners.
Future work on the HTR fuel database will concern essen-
tially the maintenance and minor upgrades as required by 
the project.
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The transmutation of americium 
Within the European framework EFTTRA the transmutation 
of americium and the fi ssion products iodine and technetium 
are studied. Two fuel capsules containing either sub-micron 
particles of americium oxide (T4-bis) or uranium oxide 
(T4-ter) in a MgAl2O4 matrix have been prepared by ITU (T4-
bis) and NRG (T4-ter) and were irradiated in the HFR. The 
irradiation lasted 653 full power days and was completed 
successfully in December 1999. 
The americium burn-up in the T4-bis sample is 99.8% and 
the overall actinide burn-up is 57%. The central temperature 
of the T4-ter pellets was measured continuously during the 
irradiation. It is observed that the temperature decreases 
gradually indicating that the thermal conductivity of 
MgAl2O4 shows suitable behaviour during irradiation. 
The Post Irradiation Examination (PIE), which was performed 
in the hot cell laboratory of NRG-Petten, was completed in 
2002. Non-destructive PIE was done on both capsules, while 
on the T4-ter capsule also destructive PIE has been done. The 
irradiation revealed strong swelling of the MgAl2O4 based 
fuel. Therefore, other types of inert matrices such as zirconia 
and new design are currently being investigated. 
The main conclusion from the above research is that the 
transmutation of americium to a high burn-up has been 
shown successfully.
TRABANT- 02
The experiment, sponsored by FZK and ITU Karlsruhe, aims 
at assessing the irradiation behaviour of two mixed oxide 
fuel pins with a high Pu content (40-45%) up to medium burn-
up. The fi rst phase of 2 cycles was completed at the start 
of the year. The resulting neutron radiograph indicated no 
damage and excellent condition for the fuel pellet/cladding 
integrity before the second irradiation phase. This second 
phase will start in 2003, after the third fuel pin, currently 
under manufacturing at ITU, is delivered (expected date 
early 2003). The irradiation will then continue for another 9 
reactor cycles.
Ø 6 cm
Ø 1 mm
TRISO coated fuel particle and fuel pebble HTR fuel pebble irradiation test HFR-EU1
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Introduction
Efforts for development of electricity generation from fusion 
started in the middle of the last century and aim at achieving 
industrial production of energy from fusion power plants in 
the middle of the 21st century. At the end of the 20th century 
the Joint European Torus (JET) experiment could produce tens 
of Megawatts during a short period of time. That amount 
of energy produced is tens of magnitude superior to results 
achieved through plasma experiments in the fi fties. The next 
step for production of energy from fusion is the International 
Thermonuclear Experimental Reactor (ITER), which is de-
signed to produce 500 thermal Megawatts during pulses 
lasting at least 1000 seconds and expected to operate in the 
next decade, using deuterium and tritium as fuel. 
To carry out the European effort on fusion technology devel-
opment, national research centres have joined forces in the 
European Fusion Development Agreement (EFDA), which, 
along with Japanese and American partners supports ITER; 
Chinese and South Korean partners are expected to join the 
initiative in the near future. The important involvement of the 
EU (Spain and France are candidate for hosting the reactor) 
in the ITER initiative is also refl ected in the HFR programme, 
as it remains a highly versatile device with extremely rel-
evant R&D capabilities for fusion power plant technology. 
The HFR contributes to the fusion technology development 
by providing experimental results utilising the HFR as the 
neutron source and the hot cell laboratory to perform post-
irradiation testing. The main areas of interest are the ITER 
vacuum vessel, the blanket development, and the develop-
ment of the reduced activation materials: chromium steel and 
ceramic composites.
The irradiation of the blanket sections with lithium ceramic 
pebbles is not limited to post-irradiation testing, but it in-
cludes the complete in-pile instrumentation for the operation 
of the helium extraction circuits of the module. In this way 
the HFR provides valuable in-pile process data for blanket 
operations in ITER.
ITER vacuum vessel
Welding is the main technology for manufacturing, mainte-
nance and repair of the ITER vacuum vessel. The vessel is 
made from Type 316L(N) steel. During operation, helium 
forms in the steel and welds due to the nuclear transmuta-
tion reaction with thermalised neutrons and boron. The 
vacuum vessel is located away from the plasma but where 
the neutrons have thermal energies near the welds. If re-
welding of irradiated Type 316L(N) steel is required (e.g. 
for maintenance) the helium can re-arrange itself in such a 
way that the heat affected zone near the weld will fracture 
in a brittle manner. Hence, there is a need to study, assess 
and model the mechanical properties (particularly welding-
induced brittle fracture) of 316L(N) steel in terms of helium 
levels. Furthermore, this must be studied for various welding 
procedures as these could even be adapted to decrease the 
brittle tendency to a certain degree.
In this framework, 10 mm thick plates have been irradiated 
in the HFR and welded afterwards in the hot cell laboratory 
to assess the maximum helium level the steel can be welded 
without brittle fracture. 
Modelling of the welding process and the helium transport in 
the heat-affected zone has then been carried out to explain 
the observed behaviour and determine the limits for the al-
lowable amounts of helium / boron in the steel.
Another structural solution contemplated in the present ITER 
design is bolting although the relaxation of the bolt force 
(under neutron irradiation) remains of great concern. In the 
HFR, an irradiation programme of stressed bolt materials 
such as Inconel625+ and martensitic steel PH-13-08Mo is 
underway. Target dose levels of 0.5, 1.0 and 2.0 displace-
ments per atom (dpa) have been selected. The stress relaxa-
tion occurring during neutron irradiation is then measured 
after irradiation .
HFR: The Programmes
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Helium cooled pebble bed blankets
In ITER, the tritium will be made from lithium in so-called blan-
kets; the feedstock for the (tritium-breeding) lithium will be in 
the form of ceramics or lithium lead. In this framework, inves-
tigation of lithium ceramics continued in 2002 in the HFR’s 
EXOTIC rig. The tritium laboratory will be used to obtain the 
maximum information from this series of irradiations.
As well as the testing of lithium ceramics, relevant sections of 
the blanket test module for ITER will be manufactured. They 
will be tested in 2003 in the HFR core, which provides a suit-
able neutronic environment, simulating very well ITER blanket 
module conditions and anticipated dose levels. The nuclear 
calculations have been fi nalised for a rig containing four test 
elements. Tests of mock-ups have been at the basis for the 
heat transfer analyses; FZK provided the characteristics of 
pebble bed deformation for the model; X-ray inspection and 
image analyses provided the pebble bed compaction levels 
needed for all the analyses. Preparations for setting-up the 
testing environment is well underway: the 72 thermocouples, 
8 purge lines and 4 self-powered neutron detectors were in 
place in December; the HFR tritium measuring station has 
been slightly revised and updated and the visually oriented 
behaviour monitoring equipment for the four test elements 
has been completed. 
Other preparations for HFR irradiations concerned the high 
fl uence irradiation of lithium ceramics and beryllium peb-
bles. Out of pile tests lead the way to the fi nal confi gura-
tion of pebbles and contact with the containers. Also creep 
testing determines the fi nal design for the high dose lithium 
ceramics irradiation named HICU. 
The HIgh DOse BEryllium irradiation rig (HIDOBE) will pro-
vide experimental data for the required beryllium grades, 
tritium transport and thermo-mechanics of beryllium pebble 
beds in ITER. The microstructure of the material will be an-
other variable. Helium production inside beryllium will be of 
major concern. The HFR neutron spectrum allows a highly 
relevant peak production level of 1500 ppm helium per 
annum, which is highly relevant for fusion blanket applica-
tions.
Steels for the ITER test blanket module
The reference steel for the ITER test blanket modules is EURO-
FER97, whose composition potentially provides a relatively 
short re-cycling period (less than a hundred years). The Euro-
pean industry has demonstrated the capability of producing 
such steels with low levels of impurities with already-existing 
standard equipment. Hence, if the need arises, reducing ac-
tivation levels could be achieved at reasonable cost through 
the development of dedicated low impurity steels fabrication 
equipment.
Given the rather complicated shapes of blanket modules, 
their fabrication requires different product forms. In addition, 
as the mechanical and thermal loads of the blankets are 
complex, mechanical testing of the steels to determine the 
design limits in irradiated conditions therefore are manda-
tory. 
In 2002, steel plate and hot iso-statically pressed (HIP) pow-
der parts have been subjected to post-irradiation creep. The 
HFR neutron irradiation preceding the testing was carried 
out at temperatures of nominally 800 K to damage levels of 
2.5 and 5 dpa. It turns out that the HIP parts showed a varia-
bility, which can be attributed to their limited homogeneity.
Furthermore, the HFR neutron irradiation was concluded up 
to a damage level of 10 dpa. Although this damage level 
exceeds the level anticipated and required for the ITER test 
module, it is relevant for the development of steel for power 
plant breeding blankets. Given that the neutron fl ux of the 
HFR is too low to accomplish end-of-life conditions, the HFR 
SPICE capsule aims for a maximum level of 15 dpa at lower 
temperatures. While the BOR-60 fast reactor carries out a 
sister programme with higher dose levels (over 30 dpa) but 
with temperature levels exceeding 600 K. Combination of 
HFR base data and that from BOR-60 irradiations must pro-
vide the prospects for utilisation of the steels for high dose 
applications for the time being. 
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Ceramic structural materials 
Fusion power plants, expected to be operational around 
mid 21st century, will have to meet certain environmental 
impact as well as cost effi ciency standards. The pre-requisite 
to meeting these targets is high thermal effi ciency which 
starts with the utilisation of high temperature resistant struc-
tural materials. Ceramics inherently have high temperature 
strength, but also brittle fracture properties, which can be 
reduced through fi bre-reinforcement. In this sense, silicon 
carbide composite materials, which combine high tempera-
ture strength and low activation properties (shown by the 
limited activation of its constituents near fusion plasma), 
are included in the materials development part of the EFDA 
long-term fusion technology programme. Several problems 
brought about by neutron irradiation remain to be solved as 
the composite becomes brittle and suffers from helium trans-
mutation products generated by the neutron fl ux. Several so-
lutions varying from more suitable fi bre production to special 
fi bre ceramics interface layers must therefore be tested in a 
fusion power plant simulating environment.
The HFR can simulate the conditions for the near plasma lo-
cations where the application of silicon carbide is expected. 
The SICCROWD rig, containing hundreds of silicon carbide 
composite specimens made by suppliers in the EU, Japan 
and the US, was irradiated at nominal temperatures of 900 
and 1200 K. Before and after the irradiation the elastic 
modulus and the heat conductivity will be determined in 
order to eliminate the specifi c differences of specimens. The 
SICCROWD irradiation was successfully completed in 2002 
up to 5 dpa. Post irradiation examination will be conducted 
in 2003.
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HFR as a Tool for Industrial Applications
The irradiation of silicon
Single crystalline silicon is used for the production of a 
large range of electronic devices, such IC-chips, transistors 
and diodes. The electrical resistivity of the silicon should be 
optimised for the specifi c application. The high electrical 
resistivity of high purity silicon can be decreased by add-
ing phosphorus (n-type doping). Adding phosphorus can be 
done either chemically (during the production of the single 
crystalline silicon from a bath of molten silicon) or by neutron 
irradiation of the single crystalline silicon. The latter proc-
ess is called neutron transmutation doping (NTD). A piece 
of silicon is exposed to a thermal neutron fl ux leading to a 
transformation of the silicon atoms into phosphorus atoms. 
The main advantage of this technique resides in the very ho-
mogeneous phosphorus distribution obtained, yielding the 
very homogeneous resistivity required for specifi c applica-
tions (e.g. rectifi ers for high-voltage DC transmission).
 
In the HFR, such neutron irradiations on cylindrical silicon 
ingots (diameter 100 mm, height about 250 mm) are 
performed on a commercial scale. The main technical chal-
lenge for the irradiation of the silicon ingots is to obtain a 
homogeneous thermal neutron distribution in the complete 
silicon ingot. This is done by continuous rotation of the ingot 
and by local absorption of the excess neutrons. In order to 
optimise the local absorption, so-called Monte Carlo neutron 
distribution computations are performed, calculating the 
spatial distribution of the thermal neutrons inside the ingot, 
whilst taking other factors into account such as the complex 
geometry of the HFR, the neutron absorption shields and 
the silicon ingot. These computations are currently used to 
design facilities that can be used for the irradiation of silicon 
ingots with a diameter larger than 100 mm.
32
List of Authors
Editors
M. Becquet
G. Gouwens-van Rijn
R.L. Moss
C.R. Chemaly
JRC – Main Contributors
M. Becquet 
R. Conrad
L. Debarberis
M. Fütterer
A. Gevers
R. May
R.L. Moss
F. Sevini
C. Ohms
A.G. Youtsos
NRG – Main Contributors
K. Bakker
K. Charlton
R. Kuperus
B. van der Schaaf
R.P.C. Schram
P.M. Stoop
P. Thijssen
F.J. Wijtsma
The editors wish to thank all other JRC and NRG staff 
who contributed to this report.
Address/Contact
European Commission – Joint Research Centre
Institute for Energy – High Flux Reactor Unit
P.O. Box 2
1755 ZG  Petten, The Netherlands
Tel.:  +31 (0)224 565151
Fax:  +31 (0)224 565615
E-mail: gerda.gouwens@cec.eu.int
Internet: http://www.jrc.org
33
References and Publications
[1] J. Ahlf, A. Zurita (editors), HFR characteristics and the 
Irradiation Facilities. EUR 15151 EN, 1993
[2] Expert group evaluation, Impact of the High Flux 
Reactor on Health Care in Europe, 1998
[3] J. Guidez (editor), Annual Report 2000. Operation of 
the High Flux Reactor Petten. EUR 19798 EN, 2000
[4] J. Guidez, A. Gevers et al, Status in 2000 of the High 
Flux Reactor fuel cycle. Paper presented at the 23rd 
international meeting on RERTR, Las Vegas (USA), 
October 2000.
[5] J. Guidez, P. Stoop. How will the High Flux Reactor 
enter the third millennium? Nuclear Engineering 
International, December 1999, no. 545, volume 44. 
p. 30-33
[6] C. Ohms, A.G. Youtsos, P. v.d. Idsert, “Structural 
Integrity Assessment based on the HFR Petten Neutron 
Beam Facilities”, Applied Physics A, 75, 2002, 
p. S1443-1445.
[7] A.G. Youtsos, C. Ohms, “European Standardization 
Activities on Residual Stress Analysis by Neutron 
Diffraction”, Applied Physics A, 75, 2002, 
p. S1715-1718.
[8] A.G. Youtsos, C. Ohms, in “ISO – Technology Trends 
Assessment: Polycrystalline materials – Determination 
of residual stresses by neutron diffraction”, Eds. G.A. 
Webster, R.W. Wimpory, Reference number ISO/TTA 
3 2001(E), ISO, Geneva, 2001, p. 33-37.
[9] H. Gripenberg, H. Keinänen, C. Ohms, H. Hänninen, 
D. Stefanescu and D. Smith, “Prediction and 
Measurement of Residual Stresses in Cladded Steel”, 
Materials Science Forum, Vol. 404-407, 2002, 
p. 861-866
[10] C. Ohms, A.G. Youtsos, “Neutron Diffraction assisted 
Residual Stress Analysis in Welded Structures”, 
p. 515-526 in Recent Advances in Experimental 
Mechanics, Ed. E.E. Gdoutos, Kluwer Academic 
Publishers, Dordrecht, Netherlands, 2002
[11] G.A. Webster, A.G. Youtsos, C. Ohms, R.C. 
Wimpory, “Draft Standard for the Measurement of 
Residual Stresses by Neutron Diffraction”, p.467-
476  in Recent Advances in Experimental Mechanics, 
Ed. E.E. Gdoutos, Kluwer Academic Publishers, 
Dordrecht, Netherlands, 2002
[12] D.E. Katsareas, C. Ohms, A.G. Youtsos, “Neutron 
Diffraction Techniques for Measuring Residual 
Stresses in Large Industrial Components”, p. 67-73 
in Proceedings of International Symposium of Multi-
scaling in Mechanics, Eds. G. Sih & C. Spyropoulos, 
NTUA, Athens, Greece, 2002
[13] A.G. Youtsos and C. Ohms, Final Report on European 
Project entitled “RESTAND” (residual stress standard 
based on neutron diffraction), Petten, 
The Netherlands, April 2002.
[14] A.G. Youtsos and C. Ohms, Final Technological 
Implementation Plan on European Project entitled 
“RESTAND” (residual stress standard based on 
neutron diffraction), Petten, The Netherlands, 
April 2002.
[15] L. Debarberis, N. Taylor, A. Eriksson, A.G. Youtsos, 
M. Bieth, F. Sevini, K. Törrönen, J. Guidez, H. 
Weisshäupl - An Integrated View of Plant Life 
Management, EC-JRC-IE Projects and Programmes. 
In: Proceedings of the Intern. Conference on Plant 
Life Management (PLIM), IAEA, 4-8 November 2002, 
Budapest (HU) IAEA report - ORA/PRO 63444
[16] A.G. Youtsos, Towards the development of an 
International Technical Specifi cation for NDT – Test 
method for determining residual stress by neutron 
diffraction, WGCS For Nuclear Industry, DG TREN, 
Brussels, 10 September 2002
[17] C. Ohms and A.G. Youtsos, Residual Stress measu-
rements in steel alloy fusion welds and aluminium 
alloy friction welds based on neutron diffraction, 
NCSR-DEMOCRITUS, Athens, 6 November 2002 
(invited lecture)
[18] A.G. Youtsos, NET – European Network on Neutron 
Techniques Standardization for Structural Integrity at
• 8th ECNDT, Barcelona, June 17- 21 2002 
 (poster presentation)
• Residual Stress Seminar, Bristol University, 
 19 February 2002
• Joint NET - ESIS TC 21 Workshop, 
 UN. of  Manchester, 6 February 2002
• ENPOWER Project Kick-off Meeting, Paris, 
 Jan 31 – Feb. 1, 2002
[19] A.G. Youtsos, European Standardization Activities on 
Residual Stress Analysis by Neutron Diffraction at
• CEN/TC 138 Plenary Meeting, Barcelona, 
 19-20 June 2002
• Joint Meeting of ENSA and EU Round-Table,
 Roskilde, Denmark, June 17-18 2002
34
[20] K. Hideghéty, W. Sauerwein, R.L. Moss, T. Hartog, R. 
Huiskamp, D. Touw, C. Vroegindeweij, M. de Vries, 
H. Fankhauser, K. Haselsberger, P. Paquis, C. Goetz, 
A. Wittig, J. Wolbers, D. Gabel, “Tissue uptake of 
borocaptate sodium in patients with glioblastoma 
in the EORTC 11961 Phase I BNCT Trial”, Int. J. of 
Radiation Oncology. Biology. Physics, 2002
[21] Rassow, J., Bourhis-Martin, E., Stecher-Rasmussen, 
F., Moss, R., Wittig, A., Sauerwein, W., “Vergleich 
der Qualitätssicherung der Leistungs- und 
Sicherheitsparameter der Bor-Neutroneneinfangt
herapieanlage von Petten/NL mit medizinischen 
Elektronenbescleunigern”, Deutscher Kongress für 
Radioonkologie, Strahlentherapie und Onkologie 
2002, 65, June 2002
[22] A. Wittig, W. Sauerwein, K. Hideghéty, R.L. Moss, 
H. Arlinghaus, F. Stecher-Rasmussen, J. Michel, P. 
Bendel, A. Zurlo, für die EORTC-BNCT Gruppe, “Bor-
Neutroneneinfangtherapie (BNCT) – Prinzipien der 
Methode und aktuelle Entwicklungen aus der EORTC-
BNCT Gruppe”, idem
[23] O. K. Harling, K. J. Riley, P. J. Binns, W.S. Kiger III, 
J. Capala, P. M. Munck af Rosenschold, K. Skold, 
I. Auterinen, T. Seren, P. Kotiluoto, J. Uusi-Simola, T. 
Seppälä, M. Marek, L. Viereb, F. Stecher- Rasmussen, 
W.P. Voorbraak, J. Morrissey, R.L. Moss, Osvaldo 
Calzetta Larrieu, H. Blaumann and J. Longhino, 
“International Dosimetry Exchange: A Status Report”, 
in Proc.: Research and Development in Neutron 
Capture Therapy, Eds: W.Sauerwein, R.L.Moss, 
A.Wittig; Essen, September 2002, Monduzzi Editore, 
ISBN 88-323-2909-3, p. 333-339
[24] J. Morrissey, R. Moss, C. Pantry, W. Sauerwein, 
A. Wittig, E. Martin, F. Stecher-Rasmussen, W. 
Voorbraak, „Verifi cation of Treatment Planning using 
the New Water Phantom at the HFR Petten”, idem, 
p. 495-498
[25] W.F.A.R Verbakel, K Hideghéty, W Sauerwein, J. 
Morrissey, F Stecher-Rasmussen, “Towards in vivo 
monitoring of neutron distributions for quality control 
of BNCT”, idem, p. 511-515
[26] N. Cerullo, G.G. Daquino, R. Moss and L. Muzi, 
“Evaluation of the Heterogeneous-Boron-Distribution 
Infl uence on the computed dose in BNCT Treatment 
Planning Systems”, idem, p. 541-545
[27] V.A. Nievaart, J.L. Kloosterman, T.H.J.J. van der 
Hagen, R.L. Moss, “Forward and adjoint Monte Carlo 
calculations for investigating the use of an adjustable 
fi lter in BNCT”, idem, p. 599-603
[28] G.G. Daquino, P.A. Salvadori, R. Moss, L. Menichetti, 
P. Pisani and J. Morrissey, “Phantom Developments 
and Measurements for detecting the Infl uence of 
Heterogeneous Boron Distribution on Treatment 
Planning”’ idem, p. 623-627
[29] C. Wojnecki, J. Morrissey, A. Wittig, E. Martin-
Bourhis, “Patient geometry modelling for treatment 
planning”’ idem, p. 637-640
[30] J. Morrissey, R. Moss, C. Pantry, W. Sauerwein, A. 
Wittig, E. Martin, F. Stecher-Rasmussen, K. Hideghety, 
„New Patient Positioning System for the Treatment of 
Patients suffering from brain metastases for malignant 
melanoma”, idem, p. 647-649
[31] Ph. Paquis, K. Hideghety, A. Wittig, C. Götz, 
Haselsberger, F. Grochulla, K. J. Wolbers, J. Heimans, 
R. Moss, F. Stecher-Rasmussen, W. Sauerwein, “Tissue 
Uptake of BSH in Patients with Glioblastomas in the 
EORTC 11961 Phase I BNCT Trial”’ idem, 
p. 1017-1021
[32] J. Morrissey, R. Moss, G. Brugal, D. Adehl, 
P. Branchard, X. Fabre, E. Martin, A. Wittig, 
W. Sauerwein, B. Turowski, “Tools to Improve 
Communication Flow between Multiple Centre 
Programmes”’ idem, p. 1027-1031
[33] A. Wittig, K. Hideghéty, P. Paquis, J. Heimans, M. 
Vos, C. Goetz, K. Haselsberger, F. Grochulla, R. 
Moss, J. Morrissey, E. Bourhis-Martin, J. Rassow, F. 
Stecher-Rasmussen, B. Turowski, M. Wiestler, M.J. 
deVries, H. Fankhauser, D. Gabel and W. Sauerwein, 
“Current clinical results of the EORTC-Study 11961”’ 
idem, p. 117-1122
[34] W.F.A.R Verbakel, K Hideghéty, J. Morrissey, W 
Sauerwein, F Stecher-Rasmussen, “Towards in vivo 
monitoring of neutron distributions for quality control 
of BNCT”, J. Physics in Medicine and Biology 47 
(2002), p. 1059-1072
35
ADIMEW Analysis of DIssimilar MEtal Welds
AMES Ageing Materials Evaluation Studies
BEPRO BEst PRactice on Oncology
BIMET Structural Integrity of Bimetallic components
BNCT Boron Neutron Capture Therapy
BWFC Boiling Water Fuel-element Capsule
BWR Boiling Water Reactor
CAPRA Consommation Accrue de Plutonium dans 
les RApides
CEA Commissariat à l’Energie Atomique
CEN The European Committee for 
Standardization
CFC Carbon Fibre Compound
CHARIOT Charpy and Compact tension specimens 
Irradiation
COVRA Centrale Organisatie Voor Radioactief Afval
DBTT Ducktile to Brittle Thermal Transition
DPA displacements per atom
EBP European Blanket Project Programme
ECN Energieonderzoek Centrum Nederland
EFTTRA Experimental Feasibility of Targets for 
TRAnsmutation
EMIR European network for Medical 
radioIsotopes and beam Research
ENEA Ente Nazionale per lo sviluppo dell’energia 
nucleare e le Energie alternative
ENIQ European Network for Inspection 
Qualifi cation
ENPOWER Nuclear Plant Operation by Optimising 
WEld Repairs
ENUKRA Embrittlement Assessment of Irradiated 
Pressure Vessel Steels
EORTC European Organisation for Research and 
Treatment of Cancer
ESTRO European Society for Therapeutic Radiology 
and Oncology
EXOTIC EXtraction Of Tritium In Ceramics
FEA Finite Element Analyses
FIMA Fissionable (Heavy) Metallic Atoms
FP Framework programme
FRAME Fracture Mechanics Based Embrittlement 
Trend Curves for the Characterisation of 
Nuclear Pressure Vessel Materials 
FZK ForschungsZentrum Karlsruhe
FZJ ForschungsZentrum Jülich
GT-MHR Gas Turbine – Modular Helium 
HABOG Hoogradioactief Afval Behandelings- en 
Opslag Gebouw
HCPB Helium-Cooled Pebble Bed
HEU High Enriched Uranium
HFR High Flux Reactor
HICU High-fl uence Irradiation of breeder 
Ceramics
HIDOBE High Dose Beryllium Irradiation Rig 
HIP Hot Isostatic Pressing
HITHEX HIgh Temperature Heat Exchanger
HTGR High Temperature Gas Cooled Reactor
HTR-TN High Temperature Reactor Technology 
Network
IAEA International Atomic Energy Agency
IE Institute for Energy
IHCP Institute for Health and Consumer Protection
INET Institute of Nuclear Energy Technology (of 
the Tsinghua University) 
INTERWELD Irradiation effects on the evolution of the 
microstructure, properties and residual 
stresses in the heat affected zone of 
stainless steel welds  
IRI Interfaculty Reactor Institute, University of 
Technology Delft (NL)
IRLA Improvement of Residual Life Assessment of 
VVER Reactor Pressure Vessel
IRMM Institute for Reference Materials and 
Measurements
ISIS Institute for Systems, Informatics and Safety
ISO International Organization for 
Standardization
ITER International Thermonuclear Experimental 
Reactor
ITU Institute for TransUranium Elements, 
Karlsruhe
JRC Joint Research Centre
LCNDF Large Component Neutron Diffraction 
Facility
LEU Low Enriched Uranium
LYRA Irradiation faciLitY for European network 
foR AMES
LOTUS Irradiation at LOw TemperatUre of 
Martensitic Steel Specimens for Fusion 
Applications
LWR Light Water Reactor
MANITU MANet IrradiaTions for fUsion applications
MOX Mixed Oxide
MTR Materials Testing Reactor
NCT Neutron Capture Therapy
NET Network on NEutron Techniques 
Glossary
36
Standardisation for Structural Integrity
NESC Network for Evaluating Structural 
Components 
NRG Nuclear Research and consultancy Group
NTD Neutron Transmutation Doping
PET Position Emission Tomography
PIE Post Irradiation Examination
PSF Pool Side Facility
PWR Pressurized Water Reactor
QA Quality Assurance
RAMO Power Ramp of MOX PWR fuel rods
REFA REloadable Facility
RESTAND Residual Stress Standard using Neutron 
Diffraction 
RPV Reactor Pressure Vessel
R&D Research and Development
SANS Small Angle Neutron Scattering
SCA Shared Cost Actions
SIANC Structural Integrity Assessment of Nuclear 
Components
SINAS Simplifi ed Na-Steel irradiation rig
SINEXT INAS NEXT type
SMT Standards, Measurements and Testing
SIWAS Simplifi ed Water-Steel irradiation
SOSIA Sodium Specimens Irradiation
SPEECH Safety of pressure equipment and 
components containing hydrogen
STRAIN STRess relAxation in Inconel bolts under 
irradiatioN
SUMO In-SodiUm Steel Mixed Specimens 
IrradiatiOn
TMS Tritium Measuring Station
TRABANT TRAnsmutation and Burning of ActiNides in 
a TRIOX
TRIO Irradiation device with three thimbles
TRIOX TRIO modifi ed for irradiation of MOX fuels
TRU TRansUranic
VAMAS Versailles Agreement on Measurement and 
Standards
VTT Technical Research Centre of Finland
European Commission
EUR 20773 EN - Operation and Utilisation of the High Flux Reactor -
 Annual Report 2002
Edited by: M. Becquet, G. Gouwens van Rijn, R.L. Moss, C.R. Chemaly
Luxembourg: Ofﬁ ce for Ofﬁ cial Publications of the European Communities
2003 - 36 pp. - 21 x 29.7 cm
Scientiﬁ c and Technical Research series
ISBN 92-894-5936-0
Abstract
The High Flux Reactor (HFR) of Petten is managed by the Institute for Energy (IE) of the 
EC - DG JRC and operated by NRG who are also responsible for commercial activities. 
The HFR, operated at 45 MW of the tank-in-pool type, light water cooled and moderated, 
is one of the most powerful multi-purpose research reactors in the world and one of the 
world leaders in target irradiation for the production of medical radioisotopes.
2002 was a challenging year during which the HFR underwent an unscheduled full cycle shutdown 
and a safety audit but nevertheless also managed, amongst others, to:
• operate 275 full-power days
• receive 150 visits involving a total of 955 people, which also included the Dutch Minister 
for Economic Affairs and a member of the US Nuclear Regulatory Commission. 
• treat the last patient in the current BNCT trial
• underpin its strategic importance in the medical radioisotopes supply chain
• launch a European Network on Neutron Techniques Standardisation  
2002 was the third year of the four-year HFR Supplementary Programme.
The mission of the JRC is to provide customer-driven scientiﬁ c and technical support for the conception, development, 
implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference 
centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the 
Member States, while being independent of special interests, whether private or national.
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